Inhibrx Biosciences Inc INBX

‎$‎75.80-6.31(-7.68%)(1D)

• Delayed prices by NASDAQ • in USD

Invest in Inhibrx Biosciences Inc
Today

Create an eToro account to buy INBX stock on a secure, user-friendly, multi-asset trading platform.

Inhibrx Biosciences Inc INBX

Buy INBX

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Colliers International Group Inc

‎$‎113.39

-4.09%

SWR.L

Smurfit WestRock Public Limited Company

3,760.35‎p‎

-1.31%

REINA.NV

Reinet Investments SCA

‎€‎31.60

+9.72%

FBIN

Fortune Brands Innovations Inc

‎$‎51.32

-17.62%

ICLR

ICON Public Limited Company

‎$‎93.00

+16.13%

MAX

*Past performance is not an indication of future results

Jump to:

About INBX >
How to Buy? >
Top Guides >

The Inhibrx Biosciences Inc share price is on the decline this week.

The Inhibrx Biosciences Inc share price today is ‎$‎75.80, reflecting a ‎-7.68‎% change over the last 24 hours and ‎-9.46‎% over the past week. The current market capitalization of INBX is ‎$‎1.1B with an average volume in the last three months of 227118.6. The stock has a P/E ratio of -7.4 and a dividend yield of 0%. With the stock’s beta sitting at 0.86

Why invest in stocks on eToro?

Start with ‎$‎50

Low fees

users worldwide

Across 70+ countries

Get Started

INBX Key Metrics

Market Cap

‎$‎1.1B

Day’s Range

‎$‎75.64 - ‎$‎83.85

52W Range

‎$‎10.65 - ‎$‎94.2

Average Volume (3M)

227118.6

Price-Earnings Ratio

-7.4

Revenue

‎$‎1.4M

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎75.8

EPS

‎$‎-10.24

Beta

0.86

How can I buy Inhibrx Biosciences Inc stocks?

To purchase Inhibrx Biosciences Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Inhibrx Biosciences Inc (INBX) page and place an order to buy Inhibrx Biosciences Inc.

Buy INBX

Looking for more information? Check out our guide on Academy.

What Is Inhibrx Biosciences Inc?

Inhibrx Inc is a global clinical-stage biotechnology company aiming to discover and develop biologic therapeutic candidates that target life-threatening conditions including oncology and orphan diseases.

Operating in the biomedical and healthcare sector, Inhibrx has a pipeline of four differentiated clinical-stage therapeutic candidates developed for the treatment of Alpha-1 Antitrypsin Deficiency (AATD) and various cancers. Inhibrx Inc. has formed collaborations and partnerships with companies such as 2seventybio and Alpha-1 Foundation with the aim of further extending its research and development.

Monitor the INBX share price by adding it to your eToro watchlist.

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Inhibrx Biosciences Inc
Today

Create an eToro account to buy INBX stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Inhibrx Biosciences Inc stock?

The current price of INBX is ‎$‎75.80.

What are analysts’ forecasts for Inhibrx Biosciences Inc?

Analysts offer forecasts for Inhibrx Biosciences Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Inhibrx Biosciences Inc?

The market capitalisation of Inhibrx Biosciences Inc is ‎$‎1.1B

Daily Movers

Explore the biggest stocks movers on the market.